Provided by Tiger Fintech (Singapore) Pte. Ltd.

Leap Therapeutics Inc

0.3860
+0.02647.34%
Post-market: 0.39990.0139+3.60%16:08 EDT
Volume:263.04K
Turnover:98.23K
Market Cap:15.93M
PE:-0.21
High:0.3939
Open:0.3540
Low:0.3421
Close:0.3596
Loading ...

Leap Therapeutics Shares Down 62.8% After Discontinuing Late-Stage Trials of Gastric Cancer Treatment

THOMSON REUTERS
·
28 Jan

Leap Therapeutics Shares Slide After Initial Mid-Stage Cancer-Drug Results

Dow Jones
·
28 Jan

BUZZ-Leap tumbles on discontinuation of gastric cancer treatment trials

Reuters
·
28 Jan

Leap Therapeutics Shares Fall 65.8% Premarket After Discontinuing Late-Stage Trial of Gastric Cancer Treatment

THOMSON REUTERS
·
28 Jan

Leap Therapeutics reports initial data from DeFianCe, DisTinGuish studies

TIPRANKS
·
28 Jan

Leap Therapeutics Inc - Sirexatamab Plus Bevacizumab and Chemotherapy Well-Tolerated

THOMSON REUTERS
·
28 Jan

Leap Therapeutics Inc - Distinguish Part C Study in Gastric Cancer Will Not Advance to Phase 3

THOMSON REUTERS
·
28 Jan

Leap Therapeutics Inc - DKK1 Levels Highly Correlated With Clinical Activity in Crc

THOMSON REUTERS
·
28 Jan

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study

PR Newswire
·
28 Jan

ADVISORY-Alert on fund raise wrongly tagged to Leap Therapeutics withdrawn

Reuters
·
18 Jan

Retail Platform Leap Raises $20 Million, Demonstrates Profitability & Adds Karen Katz to Board

THOMSON REUTERS
·
17 Jan

Leap Therapeutics Price Target Maintained With a $5.50/Share by HC Wainwright & Co.

Dow Jones
·
16 Jan

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference

PR Newswire
·
26 Nov 2024

Leap Therapeutics Inc reports results for the quarter - Earnings Summary

Reuters
·
13 Nov 2024

Leap Therapeutics Q2 2024 GAAP EPS $(0.52) Misses $(0.43) Estimate

Benzinga
·
13 Nov 2024

Leap Therapeutics Q3 Operating Income USD -17.855 Million

THOMSON REUTERS
·
13 Nov 2024

Leap Therapeutics Reports Third Quarter 2024 Financial Results

THOMSON REUTERS
·
13 Nov 2024

Leap Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
09 Nov 2024